Mathes Company, Inc. Danaher Corp Transaction History

Mathes Company, Inc.

$283 Million
Q3 2024

A detailed history of Mathes Company, Inc. transactions in Danaher Corp stock. As of the latest transaction made, Mathes Company, Inc. holds 13,946 shares of DHR stock, worth $3.29 Million. This represents 1.37% of its overall portfolio holdings.

Number of Shares

13,946

Previous 13,851 0.69%

Holding current value

$3.29 Million

Previous $3.46 Million 12.02%

% of portfolio

1.37%

Previous 1.26%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 29, 2024	BUY	$239.25 - $280.76 $22,728 - $26,672	95 Added 0.69%	13,946 $3.88 Million
Q2 2024 Aug 12, 2024	BUY	$235.51 - $267.98 $62,645 - $71,282	266 Added 1.96%	13,851 $3.46 Million
Q1 2024 May 02, 2024	SELL	$224.58 - $256.19 $1,122 - $1,280	-5 Reduced 0.04%	13,585 $3.39 Million
Q4 2023 Jan 30, 2024	BUY	$185.1 - $233.13 $2,221 - $2,797	12 Added 0.09%	13,590 $3.14 Million
Q2 2023 Jul 25, 2023	SELL	$224.99 - $256.14 $28,123 - $32,017	-125 Reduced 0.91%	13,578 $3.26 Million
Q4 2022 Jan 25, 2023	SELL	$241.42 - $282.29 $15,692 - $18,348	-65 Reduced 0.47%	13,703 $3.64 Million
Q3 2022 Oct 18, 2022	SELL	$247.06 - $1507.4 $11,117 - $67,833	-45 Reduced 0.33%	13,768 $3.56 Million
Q2 2022 Aug 01, 2022	SELL	$237.11 - $299.66 $147,245 - $186,088	-621 Reduced 4.3%	13,813 $3.5 Million
Q1 2022 Jun 15, 2022	SELL	$257.27 - $315.76 $240,547 - $295,235	-935 Reduced 6.08%	14,434 $4.23 Million
Q4 2021 Feb 04, 2022	SELL	$292.08 - $329.01 $566,927 - $638,608	-1,941 Reduced 11.21%	15,369 $5.06 Million
Q3 2021 Oct 29, 2021	SELL	$272.21 - $332.43 $396,065 - $483,685	-1,455 Reduced 7.75%	17,310 $5.27 Million
Q2 2021 Jul 20, 2021	SELL	$225.08 - $271.69 $6,752 - $8,150	-30 Reduced 0.16%	18,765 $5.04 Million
Q1 2021 Apr 28, 2021	SELL	$212.38 - $245.9 $300,942 - $348,440	-1,417 Reduced 7.01%	18,795 $4.23 Million
Q4 2020 Jan 20, 2021	SELL	$212.5 - $245.46 $307,700 - $355,426	-1,448 Reduced 6.69%	20,212 $4.49 Million
Q3 2020 Oct 26, 2020	SELL	$177.16 - $215.33 $246,252 - $299,308	-1,390 Reduced 6.03%	21,660 $4.66 Million
Q2 2020 Jul 27, 2020	SELL	$128.7 - $176.83 $27,927 - $38,372	-217 Reduced 0.93%	23,050 $4.08 Million
Q1 2020 Apr 21, 2020	SELL	$121.39 - $169.05 $316,220 - $440,375	-2,605 Reduced 10.07%	23,267 $3.22 Million
Q4 2019 Jan 30, 2020	BUY	$133.47 - $153.48 $50,051 - $57,554	375 Added 1.47%	25,872 $3.97 Million
Q3 2019 Oct 21, 2019	SELL	$135.4 - $146.47 $90,041 - $97,402	-665 Reduced 2.54%	25,497 $3.68 Million
Q2 2019 Jul 29, 2019	SELL	$124.88 - $143.73 $28,098 - $32,339	-225 Reduced 0.85%	26,162 $3.74 Million
Q1 2019 May 01, 2019	BUY	$97.62 - $132.29 $2.58 Million - $3.49 Million	26,387 New	26,387 $3.48 Million

Others Institutions Holding DHR

# of Institutions

2,508

Shares Held

542M

Call Options Held

7.07M

Put Options Held

4.55M

View Full List

About DANAHER CORP

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $172B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

More about DHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mathes Company, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Mathes Company, Inc. with notifications on news.

Account

Mathes Company, Inc. Danaher Corp Transaction History